Bota-Rabassedas, N., Wijeratne, S., Connolly, C., Wynes, M., Sanchez-Espiridion, B., Fujimoto, J., … Wistuba, I. (2023). Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC. In JOURNAL OF THORACIC ONCOLOGY (Vol. 18, pp. E26–E27).

Bota-Rabassedas, N., S. Wijeratne, C. Connolly, M. Wynes, B. Sanchez-Espiridion, J. Fujimoto, J. Posadas, et al. “Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC.” In JOURNAL OF THORACIC ONCOLOGY, 18:E26–27, 2023.

Bota-Rabassedas N, Wijeratne S, Connolly C, Wynes M, Sanchez-Espiridion B, Fujimoto J, et al. Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC. In: JOURNAL OF THORACIC ONCOLOGY. 2023. p. E26–7.

Bota-Rabassedas, N., et al. “Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC.” JOURNAL OF THORACIC ONCOLOGY, vol. 18, no. 3, 2023, pp. E26–27.

Bota-Rabassedas N, Wijeratne S, Connolly C, Wynes M, Sanchez-Espiridion B, Fujimoto J, Posadas J, Walker A, Zhu H, Dacic S, Travis W, Lee J, Kerr K, Glass C, Saqui A, Sholl L, Cooper W, Roden A, Poleri C, Chung J-H, Lopez-Martin J, Borczuk A, Weissferdt A, Wistuba I. Infrastructure for Interobserver Variability Assessment of Pathologic Response (PR), in Surgical Resection Specimens Following Neoadjuvant Immune Check Point Inhibitor (ICI) Therapies in Early Stage NSCLC. JOURNAL OF THORACIC ONCOLOGY. 2023. p. E26–E27.